Carboplatin + PEMBROLIZUMAB + CISPLATIN + Sigvotatug Vedotin

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Carboplatin + PEMBROLIZUMAB + CISPLATIN + Sigvotatug Vedotin
Treatment and conditionWhere it standsTrials
Carboplatin + PEMBROLIZUMAB + CISPLATIN + Sigvotatug Vedotin for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Carboplatin + PEMBROLIZUMAB + CISPLATIN + Sigvotatug Vedotin for uterine cervical neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1